| Date | Form | Description | Docs | XBRL | Pages |
| 01/29/96 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
44 | |
| 09/12/95 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 | |
| 09/06/95 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
15 | |
| 09/06/95 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
2 | |
| 06/30/95 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
8 | |
| 06/27/95 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
4 | |
| 06/14/95 | DEF 14A | Definitive proxy statements |
|
15 | |
| 06/09/95 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 |
Latest News & Events
Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
Read More...Anixa Biosciences CEO Provides Letter to Shareholders
Read More...Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...